NVUS - Novus Therapeutics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue----
Cost of Revenue--2,71558
Gross Profit---2,715-58
Operating Expenses
Research Development2,0223,1913,191888
Selling General and Administrative7,0991,9371,474208
Non Recurring----
Total Operating Expenses9,1215,1284,1891,154
Operating Income or Loss-9,121-5,128-4,189-1,154
Income from Continuing Operations
Total Other Income/Expenses Net-3,995-527-25-6
Earnings Before Interest and Taxes-9,121-5,128-4,189-1,154
Interest Expense----6
Income Before Tax-13,116-5,655-4,214-1,160
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-13,116-5,655-4,214-1,160
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-13,116-5,655-4,214-1,160
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-10,778-941-687-270